Case report · 2015
Research articlePublished 2014
A Biologically Conformal Intensity-Modulated Radiotherapy Framework Based on [18F] Fluoro-Deoxy-Glucose Positron Emission Tomography for Individualized Cancer Treatment
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Purpose: To develop a framework for biologically-optimized routine intensity modulated radiotherapy (IMRT) treatment plans based on 18F-fluoro-deoxy-glucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography imaging. Methods and materials: The dose-planning FDG-PET images are first corrected for partial volume effect using an iterative algorithm with a noise suppression filter. Thereafter, the FDG-uptake is used for transforming the delineated clinical target volume (CTV) into a set of biological planning target volumes (bPTV). This is done with an optimization algorithm that groups pixel values with the objective of maximizing the FDG-uptake variance between bPTV. The resulting average FDG pixel intensity within each bPTV, together with a tumor control probability (TCP) function, are used to obtain the prescribed dose to each bPTV that maximize the total TCP, using dose limits to the organs at risk (OAR) as constraints. The accuracy of this method was tested on a phantom. Additionally, this framework was also tested on five patients with head-neck cancer, in a retrospective clinical trial. Results: The extension of the obtained bPTV and their activity concentration showed good agreement with the true FDG distribution in the phantom. All patients planned using the presented methodology achieved a notable increase in TCP, compared to the standard IMRT plans. Conclusions: FDG-PET together with this framework can be used to biologically optimize IMRT to individualize cancer treatment.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2015
A Comparison of Fluro-Deoxy Glucose-Positron Emission Tomography (FDGPET)Versus Magnetic Resonance (MR) Based Target Volume Delineation in Post-operative Glioblastoma
Case report · 2015
Assessment of Sorafenib and AntiVEGF Combination Therapy Response which Added to Neoadjuvant Therapy in two Pediatric Metastatic Ewing Sarcoma Patients by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography (18F-PET) Method: It may Determine the Prognosis
Research article · 2014
Radiobiological Modeling Based on 18F-Fluorodeoxyglucose Positron Emission Tomography Data for Esophageal Cancer
Conference abstract · 14 Jul 2016
Synthesis of a [18F]-labeled ceritinib analogue for positron emission tomography of anaplastic lymphoma kinase, a receptor tyrosine kinase, in lung cancer
More from this journal
The newest in Nuclear Medicine & Radiation Therapy.
Opinion · 1 Dec 2025
Radiolabeled Antibody Conjugates: Targeting Cancer Resistance
Brief report · 1 Dec 2025
AI: Precision Radionuclide Therapy Dosimetry Advancements
Brief report · 1 Dec 2025
Multi-Isotope Therapy: Powering Precision Nuclear Oncology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNuclear Medicine & Radiation Therapy
- SubjectRadiology & Imaging
- SubjectEnergy & Power
- BylineArticles whose byline prints “Annelie Johansson”
- BylineArticles whose byline prints “Camilo J. Sanz Freire”
- BylineArticles whose byline prints “Pedro M. Collado Chamorro”
- BylineArticles whose byline prints “Susana Pérez Echagüen”
- BylineArticles whose byline prints “Gustavo A. Ossola Lentati”
- BylineArticles whose byline prints “Alejandro Sánchez-Crespo”

